| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1440-1746.2000.02150.X |
| P698 | PubMed publication ID | 10824888 |
| P2093 | author name string | M Yamamoto | |
| Y Hayashi | |||
| W Wang | |||
| L Zhou | |||
| S Suzuki | |||
| H Itoh | |||
| T Itoh | |||
| Y Kuroda | |||
| Y Morita | |||
| T Kanamaru | |||
| J A Rui | |||
| P433 | issue | 4 | |
| P921 | main subject | plasminogen | Q107129060 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 422-430 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
| P1476 | title | Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma | |
| P478 | volume | 15 |
| Q34260377 | 11-epi-Sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR signaling pathways. |
| Q34178846 | Anti-angiogenic treatment strategies for malignant brain tumors |
| Q34988660 | Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway |
| Q33264199 | Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists |
| Q35089248 | Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection |
| Q85555911 | Low expression of PAI-2 as a novel marker of portal vein tumor thrombosis and poor prognosis in hepatocellular carcinoma |
| Q26767372 | Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma |
| Q41513427 | Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver |
| Q37138893 | Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo |
| Q37821301 | Proteinases and their inhibitors in liver cancer |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q37189305 | Revisiting the biological roles of PAI2 (SERPINB2) in cancer |
| Q38804110 | Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures. |
| Q35708594 | Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways |
| Q40676271 | Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells |
| Q39493066 | Synergistic effects of the combination of β-ionone and sorafenib on metastasis of human hepatoma SK-Hep-1 cells |
| Q35179582 | Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma. |
| Q39501298 | The anti-metastatic efficacy of β-ionone and the possible mechanisms of action in human hepatocarcinoma SK-Hep-1 cells |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Search more.